20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community

22 June 2018

Medicines for Europe is committed to bringing accessible, high quality […]

Read more

Access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in Budapest

14 June 2018

The joint 24th Medicines for Europe and 21st IGBA Annual […]

Read more

Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

12 June 2018


IGBA Joins ICH Management Committee and Welcomes the Positive Vote of the General Assembly

7 June 2018


Comprehensive SPC manufacturing waiver key for patient access to medicines, jobs and growth in Europe

28 May 2018

Medicines for Europe commends the European Commission for proposing an […]

Read more

EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability

24 May 2018

The European Semester Country Specific Recommendations show that healthcare systems […]

Read more

Generics driving pharmerging market growth? ‘There is still opportunity for EU’ says Medicines for Europe

22 May 2018


Up to 25,000 pharma jobs if EU alters patent rules

21 May 2018


Biosimilar Medicines: essential for sustainable access to medicines

26 April 2018

Opening the 16th Biosimilar Medicines Conference, Keith Ridge, Chief Pharmaceutical […]

Read more

Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

26 April 2018


Subscribe to our newsletter